All Pharma News
New Publication on the Gx Inbeneo® Platform Simulator

New Publication on the Gx Inbeneo® Platform Simulator
PRESS RELEASE
18 Jan 2024
Share Share
New development partnership with Apontis Pharma

New development partnership with Apontis Pharma
PRESS RELEASE
12 Dec 2023
Share Share
Ranibizumab Launch Midas Pharma is the Marketing Authorisation Holder (MAH) of a biosimilar

Ranibizumab Launch Midas Pharma is the Marketing Authorisation Holder (MAH) of a biosimilar
PRESS RELEASE
25 Sep 2023
Share Share
Midas uses IPMA standards in project management

Midas uses IPMA standards in project management
PRESS RELEASE
15 Jun 2023
Share Share
Midas`s Ranivisio (Ranibizumab) Receives Approval in Europe

Midas`s Ranivisio (Ranibizumab) Receives Approval in Europe
EMA
05 Oct 2022
Share Share
APONTIS PHARMA and Midas Pharma agree on further development partnership for the market launch of a single pill with pan

APONTIS PHARMA and Midas Pharma agree on further development partnership for the market launch of a single pill with pan
PRESS RELEASE
19 Jul 2022
Share Share
Midas Pharma engages in the Working Group „Health in Asia“ of the OAV and GHA

Midas Pharma engages in the Working Group „Health in Asia“ of the OAV and GHA
PRESS RELEASE
05 Jul 2022
Share Share
Midas Pharma receives CEP for Propofol

Midas Pharma receives CEP for Propofol
PRESS RELEASE
23 Feb 2022
Share Share
Midas` API

Midas` API "Crotamiton" has been successfully approved in China
PRESS RELEASE
01 Feb 2022
Share Share
Midas Pharma obtains CEP for Clofazimine

Midas Pharma obtains CEP for Clofazimine
PRESS RELEASE
28 Dec 2021
Share Share